CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02421757
NCT02421757N/ACompleted
CompareCT.gov

Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)

University of Maryland, Baltimore·interventional·Posted Apr 21, 2015·Updated Nov 23, 2021

In Brief

A clinical study evaluating Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device and Placebo for Lower Back Pain. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a single-site, randomized, Single-blinded, placebo-controlled, trial of Transcutaneous Magnetic Stimulation (TCMS) for the treatment of lower back pain. TCMS will be applied locally to the back in the location of a patient's pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLower Back Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 21, 2015
Enrollment StartAug 22, 2016
Primary CompletionJun 22, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.2 years ago

Interventions

Fischell Transcutaneous Magnetic Stimulation Pain Treatment Devicedevice

Transcutaneous Magnetic Stimulation

Placebodevice

The placebo Transcutaneous device